You have 9 free searches left this month | for more free features.

City

Catonsville (2)

Baltimore (1)

Kingston (1)

Condition

Schizophrenia (2)

Alzheimer's Disease (1)

Cocaine-Related Disorders (1)

Schizoaffective Disorder (1)

Schizophreniform Disorder (1)

Overall Status

Completed (3)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

phase 2/phase 3 (1)

phase 4 (1)

Sponsor

University of Maryland, Baltimore (2)

National Institute on Drug Abuse (NIDA) (1)

Queen's University (1)

Collaborator

Johns Hopkins University (1)

Mitsubishi Tanabe Pharma Corporation (1)

National Institute of Mental Health (NIMH) (1)

Intervention

tryptophan (4)

placebo (2)

n-acetylcysteine (nac) (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (3)

NIH (1)

Study Type

Interventional (4)

tryptophan

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Schizophrenia Trial in Catonsville (Tryptophan, Placebo)

Completed

Schizophrenia

Tryptophan
Placebo

Catonsville, Maryland

Maryland Psychiatric Research Center

Dec 21, 2021

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Catonsville (N-acetylcysteine (NAC), Placebo,

Recruiting

Schizophrenia
+2 more

N-acetylcysteine (NAC)
+2 more

Catonsville, Maryland

Maryland Psychiatric Research Center (MPRC) ; the Treatment Rese

Dec 9, 2021

Cocaine-Related Disorders Trial in Baltimore (Tryptophan)

Completed

Cocaine-Related Disorders

Tryptophan

Baltimore, Maryland

Johns Hopkins University School of Medicine

Jan 11, 2017

Alzheimer's Disease Trial in Kingston (Tryptophan)

Completed

Alzheimer's Disease

Tryptophan

Kingston, Ontario, Canada

Queen's University

Sep 13, 2005